The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT

Cancer Imaging. 2020 Sep 22;20(1):68. doi: 10.1186/s40644-020-00344-9.

Abstract

Background: Positron Emission Tomography with Computed Tomography (PET/CT) is widely used in the assessment of many diseases, particularly including cancer. However, many factors can affect image quality and diagnostic performance of PET scans using FDG or other PET probes.

Main body: The aim of this pictorial essay is to review PET/CT protocols that can be useful to overcome these confounding factors in routine clinical situations, with a particular focus on pharmacological interventions and problem-oriented CT acquisition protocols.

Conclusion: Imaging protocols and representative cases will be discussed, in addition to potential contraindications and precautions to be taken.

Keywords: False-negative; Intervention; Methodology; Positron emission tomography; Protocol.

Publication types

  • Review

MeSH terms

  • Fluorodeoxyglucose F18
  • Humans
  • Positron Emission Tomography Computed Tomography / methods*
  • Positron Emission Tomography Computed Tomography / standards
  • Practice Guidelines as Topic
  • Predictive Value of Tests
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18